A reverse DCF shows INTC's $62 price implies ~16% annual EBITDA growth for 10 years, requiring revenue to more than double, margins to expand drastically, and its foundry business to grow 65x. This growth profile is priced as certain, but Intel's recent history shows -1.5% revenue CAGR, negative FCF, and massive foundry losses, creating a large gap between price and probable fundamentals. The stock is overvalued, front-running a perfect execution of a difficult turnaround. The risk/reward is poor at this price. Intel successfully executes its 18A node, secures major external foundry customers (like Terafab), achieves government-subsidized margin expansion, and exceeds growth expectations.
INTC
MED
Apr 11, 02:05
Key Points
['Price assumes perfection', 'Reverse DCF shows huge growth needed', 'Foundry ramp vs. $307M revenue', 'Negative FCF, weak margins', '32% above analyst PT']
April 11, 2026 at 02:05